Milos Jesenak

Comenius University, Slovakia
MD, Associate proffesor
Jessenius Faculty of Medicine

Scopus profile: link
Researcher ID
: X-8360-2018

Professional (scientific) interests: primary and secondary immunodeficiencies; natural, semi-synthetic and synthetic immunomodulation; vaccination of immunocompromised child; skin testing in pediatric allergology; food allergy and mechanisms of oral tolerance induction; inflammometry in respiratory medicine; bronchial asthma and other allergic respiratory diseases

Selected Publications:

  1. Vnučák, M., Graňák, K., Beliančinová, M., Jeseňák, M., Macháleková, K. K., Benko, J., Samoš, M., Dedinská, I. (2022). Acute kidney rejection after anti-SARS-CoV-2 virus-vectored vaccine – case report. Npj Vaccines, 7 (1). doi:
  2. Sokolowska, M., Rovati, G. E., Diamant, Z., Untersmayr, E., Schwarze, J., Lukasik, Z., Sava, F., Angelina, A., Palomares, O., Akdis, C. A., O’Mahony, L., Jesenak, M., Pfaar, O., Torres, M. J., Sanak, M., Dahlén, S., Woszczek, G. (2022). Effects of non‐steroidal anti‐inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses: EAACI task force on eicosanoids consensus report in times of COVID‐19. Allergy, 77 (8), 2337–2354. Portico. doi:
  3. Jesenak, M., Abou Ghayda, R., Lee, K. H., Han, Y. J., Ryu, S., Hong, S. H., Yoon, S., Jeong, G. H., Yang, J. W., Lee, H. J., Lee, J., Lee, J. Y., Effenberger, M., Eisenhut, M., Kronbichler, A., Solmi, M., Li, H., Jacob, L., Koyanagi, A., Radua, J. et. al. (2022). The global case fatality rate of coronavirus disease 2019 by continents and national income: A meta‐analysis. Journal of Medical Virology, 94(6), 2402–2413. Portico. doi:
  4. Papi, A., Jesenak, M., Alfano, F., Peroni, D., Baraldi, F., Diamant, Z. (2021). The ICQ asthma algorithm: Inhaled corticosteroid Containing resCUE (ICQ) treatment for present and future asthma management. Allergy, 77(4), 1325–1327. Portico. doi:
  5. Bobcakova, A., Barnova, M., Vysehradsky, R., Petriskova, J., Kocan, I., Diamant, Z., Jesenak, M. (2022). Activated CD8+CD38+ Cells Are Associated With Worse Clinical Outcome in Hospitalized COVID-19 Patients. Frontiers in Immunology, 13. doi:
  6. Dedinská, I., Skálová, P., Graňák, K., Vnučák, M., Baltesová, T., Žilinská, Z., Jeseňák, M. (2021). The Role of HLA Antigens and Steroid Dose on the Course of COVID-19 of Patients After Kidney Transplantation. Frontiers in Medicine, 8. doi:
  7. Jesenak, M., Thalhammer, J., Kindle, G., Nieters, A., Rusch, S., Seppänen, M. R. J., Fischer, A., Grimbacher, B., Edgar, D., Buckland, M., Mahlaoui, N., Ehl, S., Boztug, K., Brunner, J., Demel, U. F., Förster-Waldl, E., Gasteiger, L. M., Göschl, L., Kojić, M., Schroll, A., al. (2021). Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations. Journal of Allergy and Clinical Immunology, 148(5), 1332-1341.e5. doi: